Crossmark

A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy

Crossref DOI link: https://doi.org/10.1038/s41467-021-22980-w

Published Online: 2021-05-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hsu, Eric J. https://orcid.org/0000-0002-6743-2399
Cao, Xuezhi

Moon, Benjamin https://orcid.org/0000-0003-4390-3560
Bae, Joonbeom https://orcid.org/0000-0002-2502-9147
Sun, Zhichen https://orcid.org/0000-0001-7837-8407
Liu, Zhida

Fu, Yang-Xin https://orcid.org/0000-0001-8441-6617
License Information

Text and Data Mining valid from 2021-05-13

Version of Record valid from 2021-05-13
More Information

Article History

Received: 13 October 2020

Accepted: 2 April 2021

First Online: 13 May 2021

Competing interests

: The authors declare no competing interests.